Lipids, lipid-lowering drugs and lateral epicondylitis of the humerus: a drug-targeted Mendelian randomization study
The three lipid traits are not risk factors for lateral epicondylitis. LPL is a potential drug target for the prevention and treatment of LE.
Authors
- Xiang Chen (ORCID: https://orcid.org/0000-0002-1218-7912)
- Meng-Meng Liu (ORCID: https://orcid.org/0000-0003-0783-0990)
- Baohua Huang (ORCID: https://orcid.org/0000-0002-0974-9021)
- Xiaohang Bao (ORCID: https://orcid.org/0009-0008-9307-6421)
Institutions
- Guangxi Medical University (CN)
- Guangxi University of Chinese Medicine (CN)
- First Affiliated Hospital of GuangXi Medical University (CN)
Publication Details
- Journal
- Frontiers in Genetics
- Published
- 2024-09-02
- DOI
- https://doi.org/10.3389/fgene.2024.1437712
- Primary Topic
- Tendon Structure and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00